Literature DB >> 2703040

Protection against pulmonary O2 toxicity by N-acetylcysteine.

P D Wagner1, O Mathieu-Costello, D E Bebout, A T Gray, P D Natterson, C Glennow.   

Abstract

N-acetylcysteine (NAC) is a known antioxidant. We therefore investigated NAC as an agent protective against O2 toxicity in the lung. Twelve dogs were anaesthetized with sodium pentobarbital and ventilated with 100% O2 for 54 h. Five were given diluent and 7 intravenous NAC (loading dose prior to 100% O2 ventilation of 150 mg.kg-1 and maintenance dose of 20 mg.kg-1.h-1). Every 6 h, physiological evaluation of the pulmonary circulation, mechanical properties, and gas exchange was performed. Post-mortem evaluation consisted of gross examination and weighing followed by light and electron microscopy. By both functional and structural criteria, NAC protected against the effects of 100% O2. The NAC group developed significantly less increase in pulmonary vascular resistance, arterial carbon dioxide tension (PaCO2) and lung wet weight, while dynamic compliance was greater. NAC also delayed the development of abnormal ventilation-perfusion relationships and was associated with reduced pulmonary white cell accumulation, with less evidence of alveolar and interstitial oedema. NAC may well be worthy of evaluation as a therapeutic agent in human diseases characterized by oxidant damage.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2703040

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  8 in total

1.  N-acetylcysteine protects striated muscle in a model of compartment syndrome.

Authors:  Stephen R Kearns; David E O'Briain; Katherine M Sheehan; Cathal Kelly; David Bouchier-Hayes
Journal:  Clin Orthop Relat Res       Date:  2010-03-23       Impact factor: 4.176

2.  Does N-acetylcysteine increase the excretion of trace metals (calcium, magnesium, iron, zinc and copper) when given orally?

Authors:  E Hjortsø; J S Fomsgaard; N Fogh-Andersen
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 3.  Pharmacotherapy of acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; Gloria S Pryhuber; Patricia R Chess; Bruce A Davidson; Paul R Knight; Robert H Notter
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

4.  Cysteine and glutathione concentrations in plasma and bronchoalveolar lavage fluid after treatment with N-acetylcysteine.

Authors:  M M Bridgeman; M Marsden; W MacNee; D C Flenley; A P Ryle
Journal:  Thorax       Date:  1991-01       Impact factor: 9.139

Review 5.  N-acetylcysteine in COPD: why, how, and when?

Authors:  Claudio M Sanguinetti
Journal:  Multidiscip Respir Med       Date:  2016-02-03

6.  Melatonin and N- Acetylcysteine as Remedies for Tramadol-Induced Hepatotoxicity in Albino Rats.

Authors:  Elias Adikwu; Bonsome Bokolo
Journal:  Adv Pharm Bull       Date:  2017-09-25

Review 7.  GSH rescue by N-acetylcysteine.

Authors:  R Ruffmann; A Wendel
Journal:  Klin Wochenschr       Date:  1991-11-15

8.  N-Acetylcysteine in Mechanically Ventilated Rats with Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome: The Effect of Intravenous Dose on Oxidative Damage and Inflammation.

Authors:  Maros Kolomaznik; Pavol Mikolka; Juliana Hanusrichterova; Petra Kosutova; Katarina Matasova; Daniela Mokra; Andrea Calkovska
Journal:  Biomedicines       Date:  2021-12-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.